M&As this week: Everstone Capital Asia, Altus Capital Partners, SLMP

1 December 2017 (Last Updated December 1st, 2017 12:57)

Everstone Capital Asia Pte Ltd has acquired Chemopharm Sdn Bhd through its Everlife platform.

Everstone Capital Asia Pte Ltd has acquired Chemopharm Sdn Bhd through its Everlife platform.

Everstone is a Singapore-based private equity firm, while Chemopharm is a research and testing solutions provider based in Malaysia.

Private equity firm Altus Capital Partners Inc plans to acquire medical technology company MGC Diagnostics Corp (MGCD) for $50.3m through its affiliates.

The acquisition enables both the companies to quickly deliver their product offerings to customers.

Both the acquirer and target companies are based in the US.

“StatLab will be able to expand its product portfolio and enter new markets through the acquisition.”

Diagnostic supplies manufacturer SLMP LLC (doing business as StatLab Medical Products Inc) has acquired speciality laboratory products manufacturer American MasterTech Scientific Inc (AMTS Inc).

StatLab will be able to expand its product portfolio and enter new markets through the acquisition.

Medical device company GE Healthcare LLC has acquired bioprocessing company Puridify Ltd.

The target company will become part of GE Healthcare Life Sciences’ bioprocess business following the acquisition and will serve as a bioprocess research hub.

The acquisition enables GE Healthcare to integrate Puridify’s platform with its bioprocess purification products.